Antibody–drug conjugates (ADCs) constitute a relatively new group of anticancer agents,
whose first appearance took place about two decades ago, but a renewed interest occurred …

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) have led to a
substantial improvement in the prognosis of lung cancer patients by explicitly targeting the …

Cancer is the leading cause of mortality worldwide. Among all cancer types, lung cancer is
recognized as the most lethal and highly metastatic. The application of targeted …

The development of cachexia in the setting of cancer or other chronic diseases is a
significant detriment for patients. Cachexia is associated with a decreased ability to tolerate …

The insulin-like growth factor type 1 receptor (IGF-1R) is important in tumorigenesis, and its
overexpression occurs in numerous tumor tissues. To date, therapeutic approaches based …

The insulin-like growth factor (IGF)-axis was implicated in cancer progression and identified
as a clinically important therapeutic target. Several IGF-I receptor (IGF-IR) targeting drugs …

Objective Glycemic index (GI) or glycemic load (GL) has been investigated in the field of
cancer research for several years. However, the relationship between GI or GL and lung …

Background: Detection rates of early-stage lung cancer are traditionally low, which
contributes to inconsistent treatment responses and high rates of annual cancer deaths …

Esophagogastric junction adenocarcinoma (EGJA) may be associated with obesity and
overweight. Thus, any variant in energy metabolism–related gene may influence the …

Background Mammographic density (MD) is a strong breast cancer risk factor that reflects
fibroglandular and adipose tissue composition, but its biologic underpinnings are poorly …